FDA warns of fractures with osteoporosis drugs
Links shared publicly online about this topic.
- 804total visits
FDA warns of fractures with osteoporosis drugs
View full resource at health.yahoo.net
Tags: Emergency, Fracture, Osteoporosis, Osteoporosis Medication, Drug, FDA, Doctor
Most Recently Shared on October 13, 2010 at 6:04 pm By:
RT @health_tweets: FDA warns of fractures w/ osteoporosis drugs... http://dld.bz/zxBM #health
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - in Endocrinology, Osteoporosis from MedPage Today
medpagetoday.com — “WASHINGTON -- A joint FDA advisory committee will meet Friday to discuss the risks associated with long-term use of bisphosphonates and whether a drug holiday would help prevent fractures in patient” View full resource at medpagetoday.com
Most Recently Shared on September 15, 2011 at 10:56 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: FDA Panel to Weigh Break from Bisphosphonate Use - http://t.co/LRpsHfxK from @medpagetoday #health #medicine
FDA advisory panel suggests warning for bisphosphonates but does not specify wording
news-medical.net — “Two independent advisory panels to the Food and Drug Administration (FDA) on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States. They did not however mention the exact words of the safety warnings and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.” View full resource at news-medical.net
Most Recently Shared on September 12, 2011 at 3:09 pm By:
Osteoporosis News: FDA advisory panel suggests warning for bisphosphonates but does not specify wording: Two ind... http://t.co/pV4RZTU
FDA reviews safety issues of bisphosphonates for osteoporosis
news-medical.net — “An advisory committee for U.S. Food and Drug Administration meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates amid worry that their long-term use could cause rare fractures of the thighbones and affect the jawbone. The committee will evaluate whether women should temporarily stop using the drugs or use them for only a few years.” View full resource at news-medical.net
Most Recently Shared on September 7, 2011 at 7:54 am By:
Osteoporosis News: FDA reviews safety issues of bisphosphonates for osteoporosis: An advisory committee for U.S.... http://t.co/Ytvr8jT
FDA Committee to Review Osteoporosis Drugs - ABC News
abcnews.go.com — “A U.S. Food and Drug Administration advisory committee meets Friday to review the safety of a popular class of osteoporosis drugs called bisphosphonates.” View full resource at abcnews.go.com
Most Recently Shared on September 6, 2011 at 8:34 pm By:
Drugs and Devices OW OW Health
FDA to Review Safety of Osteoporosis Drugs: Popular medications linked to rare thigh fractures and jawbone death. http://t.co/B7gYyni
Osteoporosis Drugs To Be Re-Evaluated By FDA Panel Amid Fracture Concerns | ThirdAge
thirdage.com — “Osteoporosis drugs are to be re-evaluated by an FDA advisory panel on Friday amid concerns that their use can cause brittle bones.” View full resource at thirdage.com
Most Recently Shared on September 6, 2011 at 6:57 pm By:
Osteoporosis Drugs To Be Re-Evaluated By FDA Panel Amid Fracture Concerns http://t.co/WEkGvvt
Medical News: Reclast Gets FDA Kidney Failure Warning - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The osteoporosis drug zoledronic acid (Reclast) should not be used in patients with significant renal impairment, and physicians should screen patients for kidney dysfunction before starting them on t” View full resource at medpagetoday.com
Most Recently Shared on September 2, 2011 at 6:56 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: Reclast Gets FDA Kidney Failure Warning - http://t.co/3so9Jlj from @medpagetoday #health #medicine
FDA: Osteoporosis Drug Reclast Ups Kidney Failure Risk
webmd.com — “The FDA warns that the osteoporosis drug Reclast (zoledronic acid) raises the risk of kidney failure.” View full resource at webmd.com
Most Recently Shared on September 2, 2011 at 6:00 pm By:
FDA: Osteoporosis Drug Reclast Raises Kidney Failure Risk http://t.co/5OhyTtn
Medical News: Reclast Gets FDA Kidney Failure Warning - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The osteoporosis drug zoledronic acid (Reclast) should not be used in patients with significant renal impairment, and physicians should screen patients for kidney dysfunction before starting them on t” View full resource at medpagetoday.com
Most Recently Shared on September 1, 2011 at 9:35 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: Reclast Gets FDA Kidney Failure Warning - http://t.co/HfgqMdX from @medpagetoday #health #medicine
Medical News: Reclast Gets FDA Kidney Failure Warning - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The osteoporosis drug zoledronic acid (Reclast) should not be used in patients with significant renal impairment, and physicians should screen patients for kidney dysfunction before starting them on t” View full resource at medpagetoday.com
Most Recently Shared on September 1, 2011 at 7:40 pm By:
Reclast Gets FDA Kidney Failure Warning http://t.co/tR7kyDv
Medical News: Reclast Gets FDA Kidney Failure Warning - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The osteoporosis drug zoledronic acid (Reclast) should not be used in patients with significant renal impairment, and physicians should screen patients for kidney dysfunction before starting them on t” View full resource at medpagetoday.com
Most Recently Shared on September 1, 2011 at 7:20 pm By:
Reclast Gets FDA Kidney Failure Warning: (MedPage Today) -- The osteoporosis drug zoledronic… http://t.co/XbAnXqh
BONIVA (Ibandronate) drug information from MPR
empr.com — “BONIVA (Ibandronate) drug information for Bone disorders, Osteoporosis~bone metabolism from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 20, 2011 at 4:55 am By:
MPR News: BONIVA: Warnings/Precautions: atypical fractures. Adverse reactions: atypical fractures. http://bit.ly/gZdsx4
ATELVIA (Risedronate) drug information from MPR
empr.com — “ATELVIA (Risedronate) drug information for Bone disorders, Osteoporosis~bone metabolism from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on April 19, 2011 at 4:20 am By:
MPR News: ATELVIA: Warnings/Precautions: atypical fractures. Adverse reactions: atypical fractures. http://bit.ly/dHjKvB
Corrected: No fracture warning needed for OTC ulcer drugs: FDA | Reuters
reuters.com — “(Corrects story posted Mar 23, 2011 as 20110323elin013, to delete inaccurate reference in paragraph 2 to FDA changing labels. Rewrites headline and story to reflect that news is FDA conclusion that short-term,” View full resource at reuters.com
Most Recently Shared on March 24, 2011 at 11:33 pm By:
Corrected: No fracture warning needed for OTC ulcer drugs: FDA http://reut.rs/gfjhQw
Corrected: No fracture warning needed for OTC ulcer drugs: FDA | Reuters
reuters.com — “(Corrects story posted Mar 23, 2011 as 20110323elin013, to delete inaccurate reference in paragraph 2 to FDA changing labels. Rewrites headline and story to reflect that news is FDA conclusion that short-term,” View full resource at reuters.com
Most Recently Shared on March 24, 2011 at 10:26 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Corrected: No fracture warning needed for OTC ulcer drugs: FDA http://ow.ly/1bVbYi
FDA Clears OTC Heartburn Drugs After Fracture Risk Found to Be Unlikely - FoxNews.com
foxnews.com — “The FDA said over-the-counter heartburn drugs such as Prevacid and Prilosec do not appear to be associated with an increased chance of fractures and scrapped plans to update the drug labels to warn consumers of such a risk” View full resource at foxnews.com
Most Recently Shared on March 24, 2011 at 8:37 pm By:
Drugs and Devices OW OW Health
FDA Clears OTC Heartburn Drugs After Fracture Risk Found to Be Unlikely: The FDA said over-the-counter heartburn... http://fxn.ws/icYFOw
Advertisement
